HRT After 60. It’s Not Too Late. Here’s What the Evidence Says.

The advice that HRT must be stopped at 60 (or after 5 years) is outdated. Modern guidance from NAMS, the Endocrine Society, and the British Menopause Society does not impose a fixed age cap; instead, it asks the right question — does the benefit-risk balance still favor treatment for this individual? For many women, the answer is yes well into their 60s.

The “timing hypothesis” explained

The timing hypothesis holds that the cardiovascular and overall safety profile of HRT depends critically on when it is initiated. Started within 10 years of menopause or before age 60, HRT shows neutral to favorable cardiovascular effects. Started a decade or more after menopause, the same therapy may not confer the same protection and risk shifts somewhat. This is supported by the WHI age-stratified reanalyses.

Is HRT safe after 60?

Continuation past 60 in a woman who started in the timing window and is tolerating therapy well is generally safe with periodic reassessment. New initiation after 60 requires a more individualized risk-benefit conversation: cardiovascular history, breast risk, severity of symptoms, and presence of bone disease all weigh in. It is not categorically forbidden — and often appropriate.

Continuing HRT into your 60s and 70s

Many women continue HRT indefinitely with annual reassessment. The honest answer to “how long can I stay on HRT?” is: as long as the benefit-risk balance favors continuation for you. There is no universal stop date.

Benefits of HRT after 60

• Bone density preservation and reduced fracture risk.
• Continued relief of vasomotor symptoms (which persist in ~10% of women into the 70s).
• Treatment of genitourinary syndrome of menopause (GSM).
• Quality of life — sleep, mood, cognition.

Having the conversation with your provider

What to bring up: current symptoms, prior HRT history, cardiovascular history, breast disease history, fracture history, and your goals. Kindr providers evaluate late starters individually and recommend the safest effective approach — which is often transdermal estradiol with bioidentical progesterone, started low and titrated.

FAQ

Clinical sources

• NAMS 2022 Hormone Therapy Position Statement
• British Menopause Society — Timing Hypothesis
• JAMA — WHI long-term follow-up
• Endocrine Society — bioidentical hormone therapy
• ACOG — Hormone Therapy in Menopause

Related HRT guides

Explore more

• Menopause HRT service overview
• Pricing plans
• Free symptom checker
• All HRT medications
• Estrogen patch guide (Climara, Vivelle-Dot, Minivelle)
• Estrogen cream & vaginal estrogen guide
• Bioidentical hormones explained

Information on this page is for educational purposes only. Prescription medications require clinical evaluation and provider approval. Individual results vary. Not an emergency service.